Recent strategies to overcome breast cancer resistance-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

Recent strategies to overcome breast cancer resistance

Published:2024-05 Issue: Volume:197 Page:104351
ISSN:1040-8428
Container-title:Critical Reviews in Oncology/Hematology
language:en
Short-container-title:Critical Reviews in Oncology/Hematology

Author:

Khan Muhammad Muzamil,Yalamarty Satya Siva Kishan,Rajmalani Bharat Ashok,Filipczak Nina^ORCID,Torchilin Vladimir P.

Publisher

Elsevier BV

Reference118 articles.

1. Ovarian ablation in early breast cancer: overview of the randomised trials. Early Breast Cancer Trialists' Collaborative Group;Lancet,1996

2. Multidrug resistance and cancer stem cells in neuroblastoma and hepatoblastoma;Alisi;Int J. Mol. Sci.,2013

3. Selective estrogen receptor modulators;An;Asian Spine J.,2016

4. Sudan I induces genotoxic effects and oxidative DNA damage in HepG2 cells;An;Mutat. Res,2007

5. Cytostatic effect of a novel mitochondria-targeted pyrroline nitroxide in human breast cancer lines;Andreidesz;Int J. Mol. Sci.,2021

Cited by 7 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Methylation modification of non-histone proteins in breast cancer: An emerging targeted therapeutic strategy;Pharmacological Research;2024-10

2. The role of HGH1 in breast cancer prognosis: a study on immune response and cell cycle;BMC Cancer;2024-09-09

3. Applicability of Quantum Dots in Breast Cancer Diagnostic and Therapeutic Modalities—A State-of-the-Art Review;Nanomaterials;2024-08-31

4. Case report: Pyrotinib and tegafur combined with radiotherapy achieved notable response in HER2-amplified rectal cancer with multiple metastases after multiline treatments;Frontiers in Pharmacology;2024-08-13

5. Navigating the complexity of PI3K/AKT pathway in HER-2 negative breast cancer: biomarkers and beyond;Critical Reviews in Oncology/Hematology;2024-08

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号京ICP备18003416号-3